In Response to Comment on Raul E. Ruiz-Lozano et al.'s Predictive Factors for the Prognosis of Vogt-Koyanagi-Harada Disease

An aggressive treatment, including immunomodulatory therapy, is very important in preventing the development of the chronic recurrent stage in Vogt-Koyanagi-Harada (VKH) disease. However, the way of treatment is not the only factor determining the prognosis, and there are other factors that affect the outcome.

Automated summary

Aggressive treatment, including immunomodulatory therapy, is crucial in preventing the development of the chronic recurrent stage in Vogt-Koyanagi-Harada (VKH) disease, but it is not the sole determinant of prognosis as there are other factors that can influence the outcome.